Entrada Therapeutics, Inc.

NASDAQ:TRDA

Biotechnology

Healthcare
$5.03 +0.37%

+$0.03 today

Market cap
$196.93M
Beta
-0.26
P/E (TTM)
-1.7
EPS (TTM)
-$3.97
52W Low $4.93High $16.45

Volume 0.82M

Average 0.36M

Balance Sheet

Inspect the capital base behind the business.

Assets

$377.38M

FY 2025 · Annual

-28.3% YoY

Liabilities

$71.25M

FY 2025 · Annual

-27.0% YoY

Equity

$306.13M

FY 2025 · Annual

-28.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents291.06M45.16M67.6M101.21M90.39M
Short-term Investments0143.56M284.37M318.79M205.3M
Net Receivables005.88M3.68M2.58M
Inventory00000
Other Current Assets021.16M11.92M16.36M7.98M
Total Current Assets298.7M209.88M369.77M440.04M306.25M
Property, Plant & Equipment (Net)6.26M33.02M92.68M82.05M67.76M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets872K9.16M6.74M4.23M3.36M
Total Non-current Assets7.13M42.18M99.42M86.28M71.13M
Total Assets305.83M252.06M469.19M526.32M377.38M
Account Payables706K5.99M3.28M4.26M2.29M
Short-term Debt00000
Tax Payables004.02M667K0
Deferred Revenue00132.26M13.65M342K
Other Current Liabilities4.56M5.49M7.66M8.43M9.22M
Total Current Liabilities6.72M21.97M158.8M39.48M24.45M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)007.72M6.51M0
Other Non-current Liabilities396K0000
Total Non-current Liabilities396K17.53M68.04M58.16M46.79M
Total Liabilities7.12M39.5M226.83M97.64M71.25M
Common Stock3K3K3K4K4K
Retained Earnings(93.67M)(188.29M)(194.97M)(129.34M)(273.09M)
Accumulated OCI0(2.06M)195K(43K)652K
Other Stockholders Equity00000
Minority Interest00000
Total Equity298.72M212.55M242.36M428.68M306.13M
Total Debt025.94M68.23M59.21M50.93M
Net Debt(291.06M)(19.22M)628K(42M)(39.46M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$76.4M
Short-term Investments$178.4M
Receivables$2.3M
Other Current$9.7M
Total Current Assets$266.9M
PP&E (Net)$65.3M
Other Non-current$3.4M
Total Non-current Assets$68.6M
Total Assets$335.5M

Analysis

Selected assets total $335.5M for Latest. The largest visible component is Short-term Investments at $178.4M, about 53.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportOct 14, 2026
SC 13D/ASC 13D/A filingSep 10, 2026
4Statement of changes in beneficial ownershipSep 9, 2026

How much cash does TRDA have?

Entrada Therapeutics, Inc. (TRDA) reported $90.39M in cash and equivalents in fiscal 2025.

How much debt does TRDA carry?

Entrada Therapeutics, Inc. (TRDA) reported $50.93M of total debt, with net debt of -$39.46M.